Dermatological Conditions

Atopic dermatitis, often known as eczema, is a chronic, inflammatory skin disorder characterized by flaky skin lesions, intense itch, and a general deterioration in quality of life.

This research study is evaluating a new study drug called Nemolizumab, given regularly as an injection under the skin, in patients with moderate to severe atopic dermatitis not adequately controlled with topic corticosteroids. The purpose of this study is to assess the safety and efficacy of Nemolizumab compared to placebo.

The study drug is not currently approved for use in Australia. The duration of the study is 48 weeks with the opportunity to enrol in the long term extension study.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Atopic dermatitis, often known as eczema, is a chronic, inflammatory skin disorder characterized by flaky skin lesions, intense itch, and a general deterioration in quality of life. Eczema flares occur at variable and unpredictable intervals.

This research study is evaluating crisabarole ointment 2%, a steroid free topical ointment, as a long term maintenance treatment for eczema, as well as for reducing eczema flare ups, in those with mild to moderate eczema.

The duration of the study is 15 months. The study drug is not currently available on the PBS.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4
Dermatological Conditions

Atopic dermatitis, often known as eczema, is a chronic, inflammatory skin disorder characterized by flaky skin lesions, intense itch, and a general deterioration in quality of life. Eczema flares occur at variable and unpredictable intervals.

This research study is evaluating two drugs, Abrocitinib compared to Dupilumab in patients with moderate to severe atopic dermatitis on background topical corticosteroid therapy. Abrocitinib is a tablet, whilst dupilumab is given as an injection under the skin.

The duration of the study is 30 weeks with the option to enter a long term extension study following completion. The study drug is not currently available on the PBS.

Trial phase 

check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4